Cover Image

Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation

Background:In recent years, diabetic kidney disease (DKD) has emerged as a prominent factor contributing to end-stage renal disease. Tubulointerstitial inflammation and lipid accumulation have been identified as key factors in the development of DKD. Earlier research indicated that Astragaloside IV...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xianhong Li (Author), Xin Dong (Author), Liangyou Zhang (Author), Shu Zhang (Author), Weiying Huang (Author), Chao Wang (Author), Zhihao Huo (Author), Xin Li (Author), Xiwen Zhang (Author), Xiaotong Jia (Author), Gangyi Chen (Author), Bin Kuang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice
by: Ruixue Zhang, et al.
Published: (2019)

Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-κB and CaSR
by: Bin Leng, et al.
Published: (2019)

Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway
by: Qian W, et al.
Published: (2019)

CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy
by: Jing Zhao, et al.
Published: (2019)

Corrigendum to "CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy"
by: Jing Zhao, et al.
Published: (2019)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
by: Yingdong Lu, et al.
Published: (2022)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
by: Zhang L, et al.
Published: (2022)

The Role of Immune Cells in DKD: Mechanisms and Targeted Therapies
by: Peng QY, et al.
Published: (2024)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
by: Yang Liu, et al.
Published: (2021)

Activation of Platelet NLRP3 Inflammasome in Crohn's Disease
by: Ge Zhang, et al.
Published: (2021)

Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation
by: Wei Li, et al.
Published: (2019)

NLRP3 Inflammasome Is Involved in Calcium-Sensing Receptor-Induced Aortic Remodeling in SHRs
by: Xin Zhang, et al.
Published: (2019)

NLRP3 Inflammasome Plays an Important Role in the Pathogenesis of Collagen-Induced Arthritis
by: Yongfeng Zhang, et al.
Published: (2016)

Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome
by: Shikuo Rong, et al.
Published: (2019)

Fn14 exacerbates acute lung injury by activating the NLRP3 inflammasome in mice
by: Xin-Xin Guan, et al.
Published: (2022)

Bisdemethoxycurcumin Alleviates Dextran Sodium Sulfate-Induced Colitis via Inhibiting NLRP3 Inflammasome Activation and Modulating the Gut Microbiota in Mice
by: Jingfei Zhang, et al.
Published: (2022)

NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
by: Pengfei Chen, et al.
Published: (2024)

Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China
by: Haitao Zhang, et al.
Published: (2023)

The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis
by: Xiao-Nan Zhang, et al.
Published: (2022)

Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD
by: Qian Huang, et al.
Published: (2022)

Agnuside Alleviates Synovitis and Fibrosis in Knee Osteoarthritis through the Inhibition of HIF-1α and NLRP3 Inflammasome
by: Li Zhang, et al.
Published: (2021)

Therapy targeted to the NLRP3 inflammasome in chronic kidney disease
by: Yong Ji, et al.
Published: (2024)

Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis
by: Yan Fu, et al.
Published: (2021)

The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
by: Ruixue Kong, et al.
Published: (2022)

Extracellular vesicles secreted by Giardia duodenalis regulate host cell innate immunity via TLR2 and NLRP3 inflammasome signaling pathways.
by: Panpan Zhao, et al.
Published: (2021)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011)

Targeting NLRP3 Inflammasome Alleviates Synovitis by Reducing Pyroptosis in Rats with Experimental Temporomandibular Joint Osteoarthritis
by: Yinzi Xin, et al.
Published: (2022)

Chrysin Attenuates the NLRP3 Inflammasome Cascade to Reduce Synovitis and Pain in KOA Rats
by: Liao T, et al.
Published: (2020)

Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway
by: Jie Qu, et al.
Published: (2024)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
by: Dantong Wu, et al.
Published: (2021)

Ghrelin Attenuates Neuroinflammation and Demyelination in Experimental Autoimmune Encephalomyelitis Involving NLRP3 Inflammasome Signaling Pathway and Pyroptosis
by: Fei Liu, et al.
Published: (2019)

The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets
by: Tao Liang, et al.
Published: (2022)

Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy
by: Yingying Hu, et al.
Published: (2023)

Effect of NLRP3 inflammasome induced astrocyte phenotype alteration in morphine tolerance
by: Zhenyu Yuan, et al.
Published: (2024)

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
by: Wenmin Dong, et al.
Published: (2022)

NLRP3 inflammasome activation by Paracoccidioides brasiliensis.
by: Aldo Henrique Tavares, et al.
Published: (2013)